Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Brief Report
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Use advanced search instead (articles only)
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Other Conditions
Vol. 2, Issue 1, 2014
August 06, 2014 EDT
Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence
Aaron Galaznik
,
Katherine Cappell
,
Leslie Montejano
,
Geoffrey Makinson
,
Kelly H. Zou
,
Gregory Lenhart
,
varenicline
utilization
smoking cessation
out-of-pocket
Copyright Logo
ccby-4.0
•
https://doi.org/10.36469/9888
Photo by
A B E D K A Y A L I
on
Unsplash
JHEOR
1.
Galaznik A, Cappell K, Montejano L, Makinson G, Zou KH, Lenhart G. Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence.
JHEOR
. 2014;2(1):53-62.
doi:10.36469/9888
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats